Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bedossa

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsyPierre Bedossa
Digestive Diseases and Sciences|February 15, 2016
Histological Assessment of NAFLDPierre Bedossa
Annales De Pathologie|December 17, 2002
[Neoplastic intraepithelial lesions of pancreatic ducts: new entities]Pierre Bedossa
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Reversibility of hepatitis B virus cirrhosis after therapy: who and why?Pierre Bedossa
Hepatology International|July 24, 2015
Current histological classification of NAFLD: strength and limitationsPierre Bedossa
Hepatology (Baltimore, Md.)|April 23, 2014
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseasePierre Bedossa,
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Pathology of non-alcoholic fatty liver diseasePierre Bedossa
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essentialPierre Bedossa
Gastroenterology|March 23, 2016
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver DiseasePierre Bedossa, Keyur Patel
Clinics in Liver Disease|April 15, 2003
Approaches for treatment of liver fibrosis in chronic hepatitis CPierre Bedossa, Valerie Paradis
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsyPierre Bedossa
Digestive Diseases and Sciences|February 15, 2016
Histological Assessment of NAFLDPierre Bedossa
Annales De Pathologie|December 17, 2002
[Neoplastic intraepithelial lesions of pancreatic ducts: new entities]Pierre Bedossa
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Reversibility of hepatitis B virus cirrhosis after therapy: who and why?Pierre Bedossa
Hepatology International|July 24, 2015
Current histological classification of NAFLD: strength and limitationsPierre Bedossa
Hepatology (Baltimore, Md.)|April 23, 2014
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseasePierre Bedossa,
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Pathology of non-alcoholic fatty liver diseasePierre Bedossa
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essentialPierre Bedossa
Gastroenterology|March 23, 2016
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver DiseasePierre Bedossa, Keyur Patel
Clinics in Liver Disease|April 15, 2003
Approaches for treatment of liver fibrosis in chronic hepatitis CPierre Bedossa, Valerie Paradis
Pageof 27